Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies Kincell Bio and Cellipont Bioservices announced the completion of their merger to form Kincellis Advanced Therapies a U.S.-based contract development and manufacturing organization focused on cell therapies and other…
AESARA Appoints Denise Sánchez as Vice President, Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, announced that Denise Sánchez, JD, MS, MA, has joined the company as Vice President, Regulatory Counsel & Compliance Strategies. She served…
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing high-quality, cost-effective animal health products, today announced the U.S. launch of Robenacoxib Injection, the only FDA-approved bioequivalent to ONSIOR® (robenacoxib)…
Carna Health and Level Up Sign a Memorandum of Understanding to Advance Preventive Healthcare in Kazakhstan Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney-Metabolic (CKM) care, announced the signing of a Memorandum of Understanding (MOU) with Level Up to…
H.B. Fuller Announces AMS Shareholders Approve Proposed Acquisition H.B. Fuller Company the world’s largest pureplay adhesives company, today announced that shareholders of Advanced Medical Solutions Group plc (“AMS”) (LSE:AMS) approved H.B. Fuller’s proposed acquisition of AMS at specially convened meetings…
Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth Applied BioCode, Inc., a leader in high-throughput multiplex molecular diagnostics, announced financial results for the…
Propel Software Launches Manufacturing Hub Providing Seamless and Standardized Integration with 12 ERP Platforms Propel, creator of the first product value management (PVM) platform to transform how manufacturers develop, launch, and service products, today announced its Summer 2026 release highlighted…
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery IQVIA a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company pioneering…
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma Estrella Immunopharma, Inc. a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases,…
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union Pfizer Inc. and BioNTech SE announced today that the European Commission (EC) has granted marketing authorization for the companies’ 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, for active…
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development Merck known as MSD outside of the United States and Canada, announced early components of a multi-faceted strategy to provide rapid, broad and sustainable…
Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000 Immunomic Therapeutics, Inc. a clinical-stage biotechnology company and a U.S.-based subsidiary of HLB, announced that the first participant has been dosed in the Phase 1…